Quick Answer
INTEGRATED BIOPHARMA INC reported Shares Outstanding of 31.06 million shares for fiscal year 2025.
INTEGRATED BIOPHARMA INC Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 31.06M | +3.2% |
| 2024 | 30.10M | +0.5% |
| 2023 | 29.95M | +0.0% |
| 2022 | 29.95M | +0.5% |
| 2021 | 29.80M | +0.5% |
| 2020 | 29.65M | +0.3% |
| 2019 | 29.57M | +39.9% |
| 2018 | 21.14M | +0.0% |
| 2017 | 21.14M | +0.1% |
| 2016 | 21.11M | +0.0% |
| 2015 | 21.11M | +0.0% |
| 2014 | 21.11M | +0.1% |
| 2013 | 21.08M | +0.0% |
| 2012 | 21.08M | +1.0% |
| 2011 | 20.88M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | 31.09M | +2.6% | +0.1% |
| September 30, 2025 | 31.06M | +3.1% | +0.0% |
| June 30, 2025 | 31.06M | +3.2% | +2.5% |
| March 31, 2025 | 30.30M | +0.7% | +0.0% |
| December 31, 2024 | 30.30M | +0.7% | +0.6% |
| September 30, 2024 | 30.13M | +0.1% | +0.1% |
| June 30, 2024 | 30.10M | +0.5% | +0.0% |
| March 31, 2024 | 30.10M | +0.5% | +0.0% |
- INTEGRATED BIOPHARMA INC showed an increase of +3.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2011–2025 period, INTEGRATED BIOPHARMA INC’s shares outstanding has grown by 48.8% (from 20.88 million shares to 31.06 million shares).
- The most recent figure is from INTEGRATED BIOPHARMA INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 23, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: